Drug firm Alembic Pharmaceuticals on Friday said it had raised Rs 350 crore through allotment of non-convertible debentures (NCDs) on private placement basis. “The NCD committee of Alembic Pharmaceuticals Ltd... has allotted 1,500, 9 per cent rated unsecured listed redeemable non-convertible debentures (NCDs)... aggregating to Rs 150 crore under tranche I,” Alembic Pharmaceuticals said in a regulatory filing. The company said it had also allotted 2,000, 9 per cent rated unsecured listed redeemable NCDs... aggregating to Rs 200 crore.